monocrotaline and Disease Exacerbation

monocrotaline has been researched along with Disease Exacerbation in 45 studies

Research

Studies (45)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's24 (53.33)29.6817
2010's16 (35.56)24.3611
2020's5 (11.11)2.80

Authors

AuthorsStudies
Araujo, AS; Baldo, G; Belló-Klein, A; Campos-Carraro, C; Constantin, RL; Fernandes-Piedras, TRG; Schenkel, PC; Teixeira, RB; Türck, P; Visioli, F; Zimmer, A1
Eccles, CA; James, J; Kurdyukov, S; Niihori, M; Rafikov, R; Rafikova, O; Varghese, MV1
Aparicio Cordero, EA; Araujo, AS; Bahr, AC; Baldo, G; Belló-Klein, A; Campos-Carraro, C; Constantin, RL; Donatti, L; Gonzalez, E; Luz de Castro, A; Ortiz, VD; Teixeira, RB; Visioli, F; Zimmer, A1
Hu, J; Liu, S; Liu, W; Lu, S; Wang, Y; Wang, Z; Zeng, X1
Hatano, E; Iwaisako, K; Kasai, Y; Nishino, H; Okuno, M; Satoh, M; Seo, S; Taura, K; Toda, R; Yoshino, K1
Ahsan, F; Keshavarz, A; Nahar, K; Rashid, J; Raut, S1
Egashira, K; Funamoto, D; Ichimura, K; Koga, JI; Matoba, T; Nakano, K; Tsutsui, H1
Huang, Y; Jing, ZC; Li, J; Liu, YW; Meng, J; Pan, HZ; Wang, PH; Xiang, L; Yang, J; Zhang, H; Zhang, XL1
de Man, FS; Grünberg, K; Ruiter, G; Sairras, S; Schalij, I; van der Laarse, WJ; Vonk-Noordegraaf, A; Westerhof, N1
Eguchi, M; Ikeda, S; Kawano, H; Koide, Y; Kusumoto, S; Maemura, K; Sato, D1
Balestra, GM; Eerbeek, O; Mik, EG; Specht, PA; van der Laarse, WJ; Zuurbier, CJ1
Black, SM; Desai, AA; Fineman, JR; Garcia, JG; Kinchen, JM; Maltepe, E; Meadows, ML; Mohney, RP; Rafikov, R; Rafikova, O; Yuan, JX1
Gu, J; Huang, C; Lin, D; Lin, T; Lin, X; Xie, L; Zheng, S1
Chlopicki, S; Fedorowicz, A; Jakubowski, A; Kopec, G; Kutryb-Zając, B; Mateuszuk, Ł; Skórka, T; Słomińska, E; Walczak, M; Zakrzewska, A; Łomnicka, M1
Bardou, M; Dumas, M; Goirand, F; Guerard, P; Lirussi, F; Rakotoniaina, Z; Rochette, L2
Amano, S; Arai, Y; Chandra, BI; Hirose, K; Ikeda, T; Kimura, Y; Komeda, M; Kushibiki, T; Marui, A; Sakaguchi, H; Tabata, Y; Yuang, H1
Beach, S; Budd, DC; Crosby, A; Davies, RJ; Docx, C; Duggan, N; England, K; Holmes, AM; Leblanc, C; Lebret, C; Morrell, NW; Raza, F; Schindler, F; Thomas, M; Walker, C1
Crosby, A; Kim, DK; Long, L; Morrell, NW; Southwood, M; Upton, PD; Yang, X1
de Man, FS; Handoko, ML; Happé, CM; Musters, RJ; Paulus, WJ; Postmus, PE; Schalij, I; van der Laarse, WJ; Vonk-Noordegraaf, A; Westerhof, N1
Asai, K; Ishikawa, M; Mizuno, K; Sato, N; Takano, T1
Beardsworth, A; Fujita, K; Kato, M; Nakazawa, T; Sawamura, F1
Courtman, DW; Deng, Y; Ormiston, ML; Slaughter, GR; Stewart, DJ1
Gewitz, MH; Huang, J; Mathew, R; Wolk, JH1
Campian, ME; de Bakker, JM; de Bruin, K; Hardziyenka, M; Tan, HL; van Eck-Smit, BL; Verberne, HJ1
Bogaards, SJ; de Man, FS; Handoko, ML; Paulus, WJ; Postmus, PE; Schalij, I; van Ballegoij, JJ; van der Velden, J; Vonk-Noordegraaf, A; Westerhof, N1
Boonstra, A; de Man, FS; Dorfmüller, P; Eddahibi, S; Fadel, E; François, C; Guignabert, C; Handoko, ML; Humbert, M; Perros, F; Postmus, PE; Rain, S; Ruiter, G; Schalij, I; Simonneau, G; Tu, L; van der Velden, J; Vonk-Noordegraaf, A1
Furuichi, K; Iwata, Y; Kaneko, S; Sakai, Y; Shimizu, M; Wada, T; Yokoyama, H1
Guo, Q; Ko, EA; Makino, A; Pohl, NM; Smith, KA; Song, S; Wan, J; Yamamura, A; Yamamura, H; Yuan, JX; Zeifman, A; Zimnicka, AM1
Angelini, A; Calvani, M; Dalla Libera, L; Della Barbera, M; Dona, M; Gobbo, V; Mosconi, L; Peluso, G; Ravara, B; Sandri, M; Vescovo, G1
Ahn, BH; Cho, HG; Lee, HA; Lee, WJ; Lee, YM; Park, HK; Yang, EK1
Hashimoto, K; Iwase, M; Kanazawa, H; Kato, Y; Kawata, N; Koike, Y; Nishimura, M; Nishizawa, T; Noda, A; Takagi, K; Yokoi, T; Yokota, M; Yoshimori, Y1
Fujimori, A; Goto, K; Iemitsu, M; Miyauchi, T; Sakai, S; Sanagi, M; Shikama, H; Sudoh, K; Yamaguchi, I; Yuyama, H1
Jackson, EK; Mady, HH; Melhem, MF; Salah, EM; Tofovic, SP1
Dacic, S; Jackson, EK; Petrusevska, G; Tofovic, SP; Zhang, X1
Minami, S; Miyazaki, H; Mochizuki, S; Ohsawa, S; Okazaki, F; Onodera, T1
Abe, K; Chapados, R; Elliott, J; Gates, AT; Ihida-Stansbury, K; Jones, PL; Kern, M; McKean, D; Merklinger, S; Plant, A; Shimokawa, H1
Campian, ME; de Bruin-Bon, HA; Hardziyenka, M; Michel, MC; Tan, HL1
Aonuma, K; Kimura, T; Liang, J; Maruyama, H; Nagasawa, T; Onodera, M; Watanabe, S; Yamaguchi, I1
Dumitrascu, R; Eickelberg, O; Hecker, M; Knaus, P; Kouri, FM; Kwapiszewska, G; Morty, RE; Nejman, B; Peters, DM; Schermuly, RT; Seeger, W; Zakrzewicz, A1
Archer, SL; Bonnet, S; Haromy, A; McMurtry, MS; Michelakis, ED1
Dida, FA; Ikeyama, Y; Imanaka-Yoshida, K; Jiang, BH; Komada, Y; Maruyama, J; Maruyama, K; Mitani, Y; Mizoguchi, A; Sawada, H; Shimpo, H; Yamamoto, H1
Bernocchi, P; Ceconi, C; de Jong, JW; de Jonge, R; Harrison, R; Keijzer, E; Schoemaker, RG; Sharma, HS1
Irukayama-Tomobe, Y; Miyauchi, T; Sakai, S1
Adnot, S; Dortho, MP; Eddahibi, S; Frisdal, E; Gest, V; Harf, A; Lafuma, C; Lepetit, H; Levame, M; Vieillard-Baron, A1

Reviews

1 review(s) available for monocrotaline and Disease Exacerbation

ArticleYear
Nodular lesions and mesangiolysis in diabetic nephropathy.
    Clinical and experimental nephrology, 2013, Volume: 17, Issue:1

    Topics: Animals; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; Endothelial Cells; Extracellular Matrix; Glomerular Mesangium; Humans; Kidney; Monocrotaline; Renal Insufficiency, Chronic

2013

Other Studies

44 other study(ies) available for monocrotaline and Disease Exacerbation

ArticleYear
Thioredoxin system activation is associated with the progression of experimental pulmonary arterial hypertension.
    Life sciences, 2021, Nov-01, Volume: 284

    Topics: Animals; Antioxidants; Apoptosis; Cell Survival; Collagen; Disease Progression; Electrocardiography; Heart Ventricles; Hypertrophy, Right Ventricular; Male; Monocrotaline; Myocytes, Cardiac; Phosphorylation; Proto-Oncogene Proteins c-akt; Pulmonary Arterial Hypertension; Rats, Wistar; Thioredoxins

2021
Early progression of pulmonary hypertension in the monocrotaline model in males is associated with increased lung permeability.
    Biology of sex differences, 2020, 03-18, Volume: 11, Issue:1

    Topics: Animals; Blood Pressure; Capillary Permeability; Disease Models, Animal; Disease Progression; Endothelial Cells; Female; Heme; Hemolysis; HSP27 Heat-Shock Proteins; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Rats, Sprague-Dawley; Sex Characteristics; Tight Junctions

2020
The progression of pulmonary arterial hypertension induced by monocrotaline is characterized by lung nitrosative and oxidative stress, and impaired pulmonary artery reactivity.
    European journal of pharmacology, 2021, Jan-15, Volume: 891

    Topics: Animals; Arterial Pressure; Disease Models, Animal; Disease Progression; Hypertrophy, Right Ventricular; Lung; Male; Monocrotaline; Nitrosative Stress; Oxidative Stress; Pulmonary Arterial Hypertension; Pulmonary Artery; Pulmonary Edema; Rats, Wistar; Receptor, Endothelin A; Time Factors; Vascular Remodeling; Vasodilation

2021
Sacubitril/valsartan treatment relieved the progression of established pulmonary hypertension in rat model and its mechanism.
    Life sciences, 2021, Feb-01, Volume: 266

    Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Body Weight; Disease Models, Animal; Disease Progression; Drug Combinations; Hypertension, Pulmonary; Hypoxia; Male; Monocrotaline; Rats; Rats, Sprague-Dawley; Tetrazoles; Valsartan

2021
Sinusoidal Obstruction Syndrome Promotes Liver Metastatic Seeding of Colorectal Cancer Cells in a Rat Model.
    Anticancer research, 2021, Volume: 41, Issue:4

    Topics: Animals; Cell Line, Tumor; Colorectal Neoplasms; Disease Models, Animal; Disease Progression; Gene Expression Regulation, Neoplastic; Hepatic Veno-Occlusive Disease; Intercellular Adhesion Molecule-1; Liver Neoplasms; Male; Matrix Metalloproteinase 9; Monocrotaline; Rats, Inbred F344; Tumor Burden; Vascular Endothelial Growth Factor A

2021
Fasudil and DETA NONOate, Loaded in a Peptide-Modified Liposomal Carrier, Slow PAH Progression upon Pulmonary Delivery.
    Molecular pharmaceutics, 2018, 05-07, Volume: 15, Issue:5

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Chemistry, Pharmaceutical; Disease Progression; Hypertension, Pulmonary; Liposomes; Lung; Male; Monocrotaline; Myocytes, Smooth Muscle; Nitric Oxide Donors; Peptides; Polyamines; Pulmonary Artery; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Vasodilator Agents

2018
Nanoparticle-Mediated Targeting of Pitavastatin to Small Pulmonary Arteries and Leukocytes by Intravenous Administration Attenuates the Progression of Monocrotaline-Induced Established Pulmonary Arterial Hypertension in Rats.
    International heart journal, 2018, Nov-28, Volume: 59, Issue:6

    Topics: Administration, Intravenous; Animals; Disease Progression; Drug Delivery Systems; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Leukocytes; Male; Monocrotaline; Nanoparticles; Pulmonary Artery; Quinolines; Random Allocation; Rats; Rats, Sprague-Dawley; Treatment Outcome

2018
Transthoracic Pulmonary Artery Denervation for Pulmonary Arterial Hypertension.
    Arteriosclerosis, thrombosis, and vascular biology, 2019, Volume: 39, Issue:4

    Topics: Adolescent; Aldosterone; Animals; Child, Preschool; Cytokines; Disease Progression; Female; Fibrosis; Gene Expression Regulation; Humans; Hypertrophy; Lung; Male; Middle Aged; Monocrotaline; Neurotransmitter Agents; Oxidative Stress; Pulmonary Arterial Hypertension; Pulmonary Artery; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Neurotransmitter; Renin-Angiotensin System; Sympathectomy; Sympathetic Nervous System

2019
Reversibility of the monocrotaline pulmonary hypertension rat model.
    The European respiratory journal, 2013, Volume: 42, Issue:2

    Topics: Animals; Arterioles; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Echocardiography; Hemodynamics; Hypertension, Pulmonary; Liver; Male; Monocrotaline; Pulmonary Artery; Random Allocation; Rats; Rats, Wistar

2013
Adipose-derived regenerative cell therapy inhibits the progression of monocrotaline-induced pulmonary hypertension in rats.
    Life sciences, 2014, Nov-24, Volume: 118, Issue:2

    Topics: Adipose Tissue; Animals; Disease Progression; Gene Expression Profiling; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Rats, Wistar; Regenerative Medicine; RNA, Messenger; Stem Cell Transplantation; Survival Analysis; Vascular Remodeling; Weight Gain

2014
Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
    Respiratory research, 2015, Feb-03, Volume: 16

    Topics: Administration, Inhalation; Animals; Arterial Pressure; Cardiotonic Agents; Disease Models, Animal; Disease Progression; Dobutamine; Energy Metabolism; Heart Failure; Hexokinase; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; L-Lactate Dehydrogenase; Male; Mitochondria, Heart; Monocrotaline; Oxygen; Oxygen Consumption; Protoporphyrins; Pulmonary Artery; Rats, Wistar; Ventricular Dysfunction, Right; Ventricular Function, Right

2015
Metabolic Changes Precede the Development of Pulmonary Hypertension in the Monocrotaline Exposed Rat Lung.
    PloS one, 2016, Volume: 11, Issue:3

    Topics: Animals; Blood Pressure; Carnitine; Disease Models, Animal; Disease Progression; Glutathione; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Male; Metabolic Networks and Pathways; Metabolome; Monocrotaline; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Time Factors

2016
(1)H NMR-Based Analysis of Serum Metabolites in Monocrotaline-Induced Pulmonary Arterial Hypertensive Rats.
    Disease markers, 2016, Volume: 2016

    Topics: Animals; Arterial Pressure; Disease Models, Animal; Disease Progression; Energy Metabolism; Glycolysis; Hypertension, Pulmonary; Lipid Metabolism; Male; Metabolome; Methionine; Monocrotaline; Proton Magnetic Resonance Spectroscopy; Pulmonary Artery; Rats; Rats, Sprague-Dawley

2016
Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.
    Respiratory research, 2016, 08-31, Volume: 17, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Animals; Case-Control Studies; Disease Models, Animal; Disease Progression; Endothelin-1; Epoprostenol; Female; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Liver; Lung; Male; Middle Aged; Monocrotaline; Niacinamide; Nicotinamide N-Methyltransferase; Nitric Oxide; Rats, Wistar; Signal Transduction; Time Factors; Ventricular Dysfunction, Right; Ventricular Function, Right

2016
Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat.
    Naunyn-Schmiedeberg's archives of pharmacology, 2008, Volume: 378, Issue:3

    Topics: Acetylcholine; Animals; Atorvastatin; Blotting, Western; Body Weight; Caspase 3; Celecoxib; Cyclooxygenase Inhibitors; Disease Progression; Drug Combinations; Hemodynamics; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Myocardium; Nitric Oxide Synthase Type III; Pulmonary Artery; Pyrazoles; Pyrroles; Rats; Rats, Wistar; Sulfonamides; Survival Analysis; Vasodilator Agents

2008
Novel approach with intratracheal administration of microgelatin hydrogel microspheres incorporating basic fibroblast growth factor for rescue of rats with monocrotaline-induced pulmonary hypertension.
    The Journal of thoracic and cardiovascular surgery, 2008, Volume: 136, Issue:5

    Topics: Animals; Blood Gas Analysis; Body Weight; Disease Progression; Fibroblast Growth Factor 2; Gelatin; Hemodynamics; Hydrogels; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Male; Microspheres; Monocrotaline; Rats; Rats, Wistar; Trachea

2008
Activin-like kinase 5 (ALK5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by monocrot
    The American journal of pathology, 2009, Volume: 174, Issue:2

    Topics: Animals; Blotting, Western; Bone Morphogenetic Protein Receptors, Type II; Cell Proliferation; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Image Processing, Computer-Assisted; Imidazoles; Immunohistochemistry; Monocrotaline; Muscle, Smooth, Vascular; Protein Serine-Threonine Kinases; Pulmonary Artery; Quinoxalines; Rats; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; Smad3 Protein; Transforming Growth Factor beta1

2009
Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease.
    Circulation, 2009, Feb-03, Volume: 119, Issue:4

    Topics: Animals; Benzamides; Bone Morphogenetic Protein Receptors, Type II; Bone Morphogenetic Proteins; Cell Movement; Chronic Disease; Disease Models, Animal; Disease Progression; Hypertension, Pulmonary; Hypoxia; Male; Monocrotaline; Muscle, Smooth, Vascular; Protein Serine-Threonine Kinases; Quinolines; Rats; Rats, Sprague-Dawley; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta

2009
Opposite effects of training in rats with stable and progressive pulmonary hypertension.
    Circulation, 2009, Jul-07, Volume: 120, Issue:1

    Topics: Adaptation, Physiological; Animals; Biopsy; Capillaries; Cardiac Catheterization; Cardiac Output; Coronary Circulation; Disease Models, Animal; Disease Progression; Echocardiography; Heart Failure; Hypertension, Pulmonary; Male; Monocrotaline; Myocarditis; Physical Conditioning, Animal; Physical Endurance; Rats; Rats, Wistar; Rest; Survival Rate

2009
Effects of a pure alpha/beta-adrenergic receptor blocker on monocrotaline-induced pulmonary arterial hypertension with right ventricular hypertrophy in rats.
    Circulation journal : official journal of the Japanese Circulation Society, 2009, Volume: 73, Issue:12

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Disease Models, Animal; Disease Progression; Heart Rate; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Myocytes, Cardiac; Propanolamines; Rats; Rats, Wistar; Sympathetic Nervous System; Ventricular Pressure

2009
Tadalafil, a long-acting inhibitor of PDE5, improves pulmonary hemodynamics and survival rate of monocrotaline-induced pulmonary artery hypertension in rats.
    Journal of pharmacological sciences, 2009, Volume: 111, Issue:3

    Topics: Animals; Blood Gas Analysis; Carbolines; Cyclic GMP; Disease Progression; Dose-Response Relationship, Drug; Hemodynamics; Hydrogen-Ion Concentration; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Organ Size; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Poisons; Pulmonary Circulation; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Survival; Tadalafil

2009
The enzymatic degradation of hyaluronan is associated with disease progression in experimental pulmonary hypertension.
    American journal of physiology. Lung cellular and molecular physiology, 2010, Volume: 298, Issue:2

    Topics: Animals; Disease Progression; Glucuronosyltransferase; Hyaluronan Synthases; Hyaluronic Acid; Hyaluronoglucosaminidase; Hypertension, Pulmonary; Lung; Male; Molecular Weight; Monocrotaline; Rats; Rats, Inbred F344

2010
Progressive endothelial cell damage in an inflammatory model of pulmonary hypertension.
    Experimental lung research, 2010, Volume: 36, Issue:1

    Topics: Animals; Cytosol; Disease Progression; Endothelial Cells; Gene Expression; Hypertension, Pulmonary; Inflammation; Male; Membrane Proteins; Monocrotaline; Nitric Oxide; Proteins; Rats; Rats, Sprague-Dawley; Signal Transduction; Time Factors

2010
Early inflammatory response during the development of right ventricular heart failure in a rat model.
    European journal of heart failure, 2010, Volume: 12, Issue:7

    Topics: Animals; Autoradiography; Disease Models, Animal; Disease Progression; Gallium Radioisotopes; Gene Expression Profiling; Heart Failure; Hypertrophy, Right Ventricular; Immunochemistry; Inflammation; Male; Monocrotaline; Myocardium; Neutrophil Activation; Peroxidase; Radionuclide Imaging; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Right

2010
Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension.
    Circulation. Heart failure, 2012, Volume: 5, Issue:1

    Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Antihypertensive Agents; Bisoprolol; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Echocardiography; Fibrosis; Heart Failure; Heart Ventricles; Hypertension, Pulmonary; Male; Monocrotaline; Rats; Rats, Wistar; Signal Transduction; Vascular Resistance

2012
Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension.
    American journal of respiratory and critical care medicine, 2012, Oct-15, Volume: 186, Issue:8

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Case-Control Studies; Cells, Cultured; Disease Progression; Endothelium, Vascular; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Losartan; Male; Middle Aged; Monocrotaline; Myocytes, Smooth Muscle; Proportional Hazards Models; Rats; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Up-Regulation

2012
Dihydropyridine Ca(2+) channel blockers increase cytosolic [Ca(2+)] by activating Ca(2+)-sensing receptors in pulmonary arterial smooth muscle cells.
    Circulation research, 2013, Feb-15, Volume: 112, Issue:4

    Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Cells, Cultured; Cytosol; Disease Progression; Humans; Hypertension, Pulmonary; Inositol Phosphates; Male; Monocrotaline; Myocytes, Smooth Muscle; Naphthalenes; Nifedipine; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing; Recombinant Fusion Proteins; Signal Transduction; Transfection; Up-Regulation; Vasoconstriction

2013
L-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure.
    American journal of physiology. Cell physiology, 2002, Volume: 283, Issue:3

    Topics: Angiotensin II; Animals; Apoptosis; Carnitine; Caspase 3; Caspase 9; Caspases; Cell Nucleus; Cells, Cultured; Cytoprotection; Disease Models, Animal; Disease Progression; Drug Evaluation, Preclinical; Glucose Transporter Type 4; Heart Failure; In Situ Nick-End Labeling; Liver Function Tests; Male; Monocrotaline; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Muscular Disorders, Atrophic; Myosin Heavy Chains; Protein Isoforms; Rats; Rats, Sprague-Dawley; Sphingolipids; Staurosporine; Tumor Necrosis Factor-alpha

2002
Estrogen and enalapril attenuate the development of right ventricular hypertrophy induced by monocrotaline in ovariectomized rats.
    Journal of Korean medical science, 2003, Volume: 18, Issue:5

    Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Body Weight; Densitometry; Disease Progression; Enalapril; Endothelin-1; Estrogens; Female; Hypertrophy, Right Ventricular; Male; Microscopy, Electron; Monocrotaline; Ovariectomy; Rats; Rats, Sprague-Dawley; Renin; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Sex Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling

2003
Progressive development of pulmonary hypertension leading to right ventricular hypertrophy assessed by echocardiography in rats.
    Experimental animals, 2003, Volume: 52, Issue:4

    Topics: Animals; Disease Models, Animal; Disease Progression; Echocardiography; Echocardiography, Doppler, Pulsed; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Pulmonary Artery; Rats; Rats, Wistar

2003
YM598, an orally active ET(A) receptor antagonist, ameliorates the progression of cardiopulmonary changes and both-side heart failure in rats with cor pulmonale and myocardial infarction.
    Journal of cardiovascular pharmacology, 2004, Volume: 44 Suppl 1

    Topics: Administration, Oral; Animals; Cardiovascular Agents; Coronary Vessels; Disease Models, Animal; Disease Progression; Endothelin A Receptor Antagonists; Heart Failure; Hemodynamics; Hypertension, Pulmonary; Ligation; Male; Monocrotaline; Myocardial Infarction; Pulmonary Heart Disease; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; Sulfonamides

2004
Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats.
    Journal of cardiovascular pharmacology, 2005, Volume: 46, Issue:4

    Topics: 2-Methoxyestradiol; Animals; Blood Pressure; Body Weight; Cell Proliferation; Disease Progression; Estradiol; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Immunohistochemistry; Lung; Male; Monocrotaline; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Time Factors; Tubulin Modulators

2005
2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Vascular pharmacology, 2006, Volume: 45, Issue:6

    Topics: 2-Methoxyestradiol; Analysis of Variance; Animals; Blood Pressure; Disease Progression; Estradiol; Female; Heart Ventricles; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Monocrotaline; Ovariectomy; Pulmonary Artery; Rats; Time Factors; Ventricular Function, Left; Ventricular Function, Right

2006
The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
    Naunyn-Schmiedeberg's archives of pharmacology, 2006, Volume: 373, Issue:6

    Topics: Acetylcholine; Animals; Apoptosis; Blood Pressure; Blotting, Western; Body Weight; Caspase 3; Disease Progression; Endothelial Cells; Heart Function Tests; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Immunohistochemistry; In Situ Nick-End Labeling; Lung; Male; Monocrotaline; Nitric Oxide Synthase Type III; Nitroprusside; Poisons; Pravastatin; Pulmonary Artery; Rats; Rats, Wistar; Survival; Vasodilator Agents

2006
Myocyte morphological characteristics differ between the phases of pulmonary hypertension-induced ventricular hypertrophy and failure.
    International heart journal, 2006, Volume: 47, Issue:4

    Topics: Animals; Cardiomegaly; Disease Models, Animal; Disease Progression; Heart Failure; Hypertension, Pulmonary; Male; Monocrotaline; Muscle Cells; Myocardium; Prognosis; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Ventricular Pressure; Ventricular Remodeling

2006
ROCK controls matrix synthesis in vascular smooth muscle cells: coupling vasoconstriction to vascular remodeling.
    Circulation research, 2006, Oct-13, Volume: 99, Issue:8

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Actins; Animals; Blood Vessels; Cell Adhesion; Cell Shape; Cells, Cultured; Cytoskeleton; Disease Progression; Extracellular Matrix; Extracellular Signal-Regulated MAP Kinases; Hypertension; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pulmonary Artery; Rats; rho-Associated Kinases; rhoA GTP-Binding Protein; Stress, Mechanical; Tenascin; Transcription, Genetic; Vasoconstriction

2006
Sequence of echocardiographic changes during development of right ventricular failure in rat.
    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2006, Volume: 19, Issue:10

    Topics: Animals; Disease Models, Animal; Disease Progression; Heart Failure; Male; Monocrotaline; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography; Ventricular Dysfunction, Right

2006
Granulocyte colony-stimulating factor prevents progression of monocrotaline-induced pulmonary arterial hypertension in rats.
    Circulation journal : official journal of the Japanese Circulation Society, 2007, Volume: 71, Issue:1

    Topics: Animals; Cell Movement; Cell Proliferation; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Echocardiography; Endothelium, Vascular; Granulocyte Colony-Stimulating Factor; Hypertension, Pulmonary; Male; Monocrotaline; Pulmonary Artery; Rats; Rats, Inbred F344

2007
Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension.
    Arteriosclerosis, thrombosis, and vascular biology, 2007, Volume: 27, Issue:5

    Topics: Animals; Apoptosis; Bone Morphogenetic Protein Receptors, Type I; Bone Morphogenetic Protein Receptors, Type II; Cell Proliferation; Disease Models, Animal; Disease Progression; Down-Regulation; Hypertension, Pulmonary; Immunoblotting; Immunohistochemistry; Male; Monocrotaline; Polymerase Chain Reaction; Pulmonary Artery; Rats; Rats, Sprague-Dawley; RNA; Signal Transduction; Smad4 Protein; Smad5 Protein; Smad6 Protein; Smad8 Protein

2007
Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension: the rapamcyin-atorvastatin-simvastatin study.
    American journal of physiology. Lung cellular and molecular physiology, 2007, Volume: 293, Issue:4

    Topics: Animals; Atorvastatin; Blood Pressure; Disease Progression; Dose-Response Relationship, Drug; Drug Synergism; Echocardiography; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Male; Monocrotaline; Phosphorylation; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 70-kDa; Simvastatin; Sirolimus

2007
A nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats.
    Chest, 2007, Volume: 132, Issue:4

    Topics: Animals; Antioxidants; Disease Progression; Hypertension, Pulmonary; Immunohistochemistry; Lung; Macrophages; Male; Monocrotaline; NF-kappa B; Pyrrolidines; Rats; Rats, Sprague-Dawley; Thiocarbamates; Vascular Cell Adhesion Molecule-1

2007
Enhanced expression and activity of xanthine oxidoreductase in the failing heart.
    Journal of molecular and cellular cardiology, 2000, Volume: 32, Issue:11

    Topics: Animals; Coronary Vessels; Disease Models, Animal; Disease Progression; Enzyme Induction; Female; Free Radicals; Heart Failure; Heart Ventricles; Hypertrophy, Right Ventricular; Ligation; Monocrotaline; Muscle Proteins; Myocardial Infarction; Organ Size; Rats; Rats, Sprague-Dawley; Xanthine Oxidase

2000
Chronic treatment with probucol effectively inhibits progression of pulmonary hypertension in rats.
    Life sciences, 2000, Sep-08, Volume: 67, Issue:16

    Topics: Animals; Anticholesteremic Agents; Blood Pressure; Diet; Disease Progression; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Probucol; Rats; Rats, Wistar; Ventricular Dysfunction, Right; Ventricular Function, Right; Ventricular Pressure

2000
Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension.
    The European respiratory journal, 2001, Volume: 18, Issue:5

    Topics: Animals; Disease Progression; Hypertension, Pulmonary; Hypoxia; Male; Matrix Metalloproteinase 2; Models, Animal; Monocrotaline; Pulmonary Artery; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction

2001